National Cancer Institute; Notice of Meeting, 13308 [2019-06571]
Download as PDF
<![CDATA[
jbell on DSK30RV082PROD with NOTICES
13308
Federal Register / Vol. 84, No. 65 / Thursday, April 4, 2019 / Notices
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Comprehensive Partnerships to Advance
Cancer Health Equity (CPACHE) (U54).
Date: May 3, 2019.
Time: 7:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville Hotel,
1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W108,
Bethesda, MD 20892–9750, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Improving
Smoking Cessation Interventions Among
People Living with HIV (R01 & R21).
Date: June 6, 2019.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W238, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Byeong-Chel Lee, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W238, Bethesda, MD 20892–9750,
240–276–7755, byeong-chel.lee@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project IV (P01).
Date: June 6–7, 2019.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Jennifer C. Schiltz, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W112, Bethesda, MD
20892–9750, 240–276–5864, jennifer.schiltz@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; IMAT
Biospecimen Research.
Date: June 20, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W246, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology &
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Bethesda, MD 20892–9750,
240–276–5460, jfang@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
VerDate Sep<11>2014
17:25 Apr 03, 2019
Jkt 247001
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 29, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–06568 Filed 4–3–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meeting will be open to the
public to attend or dial-in, with inperson attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee; Translational
Research Strategy Subcommittee (TRSS).
Date: May 8, 2019.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: Review the Glioblastoma (GBM)
Working Group Report.
Place: National Institutes of Health,
Building 31, Room 11A01, 31 Center Drive,
Bethesda, MD 20892, (Join by Phone), 855–
259–6342 [Toll Free], Conference
Code:1102766460, Passcode: 6460.
Contact Person: Peter Ujhazy, MD, Ph.D.,
Deputy Associate Director, Translational
Research Program, Division of Cancer
Treatment and Diagnosis, National Institutes
of Health, National Cancer Institute, 9609
Medical Center Drive. Room 3W106,
Rockville, MD 20850, 240–276–5681,
ujhazyp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ctac/ctac.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 29, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–06571 Filed 4–3–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–R8–ES–2019–N002;
FXES11140800000–190–FF08E00000]
Draft City of Rancho Palos Verdes
Natural Community Conservation Plan
and Habitat Conservation Plan and
Draft Environmental Assessment, City
of Rancho Palos Verdes, Los Angeles
County, California
Fish and Wildlife Service,
Interior.
ACTION: Notice of availability; request
for public comment.
AGENCY:
We, the U.S. Fish and
Wildlife Service (Service), announce the
recirculation of the draft Natural
Community Conservation Plan/Habitat
Conservation Plan (NCCP/HCP) and
draft environmental assessment (draft
EA), which evaluates the impacts of,
and alternatives to, the proposed City of
Rancho Palos Verdes (City of RPV)
NCCP/HCP. The recirculation is
necessary to maximize public review
because, while the document provided
during the initial 60-day comment
period was the document considered by
the City of RPV Council at their March
29, 2018, Council Meeting, it did not
include changes accepted by City of
RPV Council via late correspondence at
the Council Meeting, nor did it include
technical and clarifying edits made after
the Council Meeting. We request review
and comment on the City of RPV NCCP/
HCP and the draft EA from local, State,
and Federal agencies; Tribes; and the
public.
DATES: To ensure consideration, please
send your written comments by May 6,
2019.
SUMMARY:
E:\FR\FM\04APN1.SGM
04APN1
]]>Agencies
[Federal Register Volume 84, Number 65 (Thursday, April 4, 2019)]
[Notices]
[Page 13308]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06571]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meeting will be open to the public to attend or dial-in, with
in-person attendance limited to space available. Individuals who plan
to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
Name of Committee: National Cancer Institute Clinical Trials and
Translational Research Advisory Committee; Translational Research
Strategy Subcommittee (TRSS).
Date: May 8, 2019.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: Review the Glioblastoma (GBM) Working Group Report.
Place: National Institutes of Health, Building 31, Room 11A01,
31 Center Drive, Bethesda, MD 20892, (Join by Phone), 855-259-6342
[Toll Free], Conference Code:1102766460, Passcode: 6460.
Contact Person: Peter Ujhazy, MD, Ph.D., Deputy Associate
Director, Translational Research Program, Division of Cancer
Treatment and Diagnosis, National Institutes of Health, National
Cancer Institute, 9609 Medical Center Drive. Room 3W106, Rockville,
MD 20850, 240-276-5681, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 29, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-06571 Filed 4-3-19; 8:45 am]
BILLING CODE 4140-01-P
